$2.56
30.72% yesterday
Nasdaq, Oct 01, 10:16 pm CET
ISIN
US34960Q1094
Symbol
FBIO

Fortress Biotech, Inc. Stock price

$2.56
-0.02 0.78% 1M
+1.02 66.23% 6M
+0.54 26.42% YTD
+1.13 79.02% 1Y
-10.24 80.01% 3Y
-57.89 95.77% 5Y
-32.84 92.77% 10Y
-147.44 98.29% 20Y
Nasdaq, Closing price Wed, Oct 01 2025
-1.14 30.72%
ISIN
US34960Q1094
Symbol
FBIO
Industry

Key metrics

Basic
Market capitalization
$109.9m
Enterprise Value
$89.3m
Net debt
positive
Cash
$74.4m
Shares outstanding
29.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.9 | 1.3
EV/Sales
1.5 | 1.0
EV/FCF
negative
P/B
2.5
Financial Health
Equity Ratio
15.8%
Return on Equity
-245.8%
ROCE
-105.7%
ROIC
-210.2%
Debt/Equity
1.2
Financials (TTM | estimate)
Revenue
$59.3m | $86.4m
EBITDA
$-102.7m | $-127.3m
EBIT
$-108.2m | $-101.7m
Net Income
$-24.1m | $-24.0m
Free Cash Flow
$-80.1m
Growth (TTM | estimate)
Revenue
-28.2% | 49.8%
EBITDA
-13.6% | -18.1%
EBIT
-13.8% | 8.6%
Net Income
51.5% | 57.1%
Free Cash Flow
23.0%
Margin (TTM | estimate)
Gross
70.9%
EBITDA
-173.2% | -147.3%
EBIT
-182.5%
Net
-40.6% | -27.7%
Free Cash Flow
-135.1%
More
EPS
$-0.8
FCF per Share
$-2.7
Short interest
16.1%
Employees
101
Rev per Employee
$570.0k
Show more

Is Fortress Biotech, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Fortress Biotech, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Fortress Biotech, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Fortress Biotech, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Fortress Biotech, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
59 59
28% 28%
100%
- Direct Costs 17 17
33% 33%
29%
42 42
26% 26%
71%
- Selling and Administrative Expenses 113 113
42% 42%
191%
- Research and Development Expense 31 31
56% 56%
53%
-103 -103
14% 14%
-173%
- Depreciation and Amortization 5.55 5.55
17% 17%
9%
EBIT (Operating Income) EBIT -108 -108
14% 14%
-183%
Net Profit -24 -24
51% 51%
-41%

In millions USD.

Don't miss a Thing! We will send you all news about Fortress Biotech, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortress Biotech, Inc. Stock News

Neutral
GlobeNewsWire
about 7 hours ago
LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fortress Biotech Inc., ("Slide" or the "Company") (NASDAQ: FBIO) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Neutral
GlobeNewsWire
about 11 hours ago
ATLANTA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Fortress Biotech, Inc. (“Fortress” or the “Company”) (NASDAQ: FBIO) complied with federal securities laws. On October 1, 2025, Fortress and its subsidiary, Cyprium Therapeutics, Inc., announced that the FDA issued a Complete Response Letter (“CRL”) relating to the New Drug Application (“NDA”) for CUTX-101 a...
Neutral
GlobeNewsWire
about 15 hours ago
Dotinurad is a next-generation URAT1 inhibitor in two Phase 3 clinical trials with potential for best-in-class safety and efficacy
More Fortress Biotech, Inc. News

Company Profile

Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.

Head office United States
CEO Lindsay Rosenwald
Employees 101
Founded 2006
Website www.fortressbiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today